
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
John Hyttel
![]()
John Hyttel is one of the founders of Zealand Pharma and has been with the company since its start in 1998, first as Vice president for Biology and later as Head of Regulatory Affairs, Quality Assurance and Documentation. Dr. Hyttel was appointed Senior Vice President for Operations March 1st, 2010. He holds a M.Sc. in biochemistry and a D.Sc. degree both from the University of Copenhagen. Dr. Hyttel has more than 40 years experience in Research and Development. He served H. Lundbeck A/S from 1968 to 1998, the last 10 years as Director of Pharmacological Research and as member of the R&D Management team.
Phone: +45 4328 1201
e-mail: jhy@zp.dk
Fill in the form below to tip a friend about this page.
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 27.7.2010